San Diego, CA – June 28, 2016- Objective Capital Partners is pleased to announce that Channing Hamlet, one of its Managing Directors, has been invited ...
San Diego, CA – June 7, 2016- Regen BioPharma, Inc. (OTCQB: RGBP), (OTCQB: RGBPP), announced today that it has retained Objective Capital Partners, LLC as ...
San Diego, CA and Bothell, WA – May 17, 2016 – Marina Biotech, Inc. (OTCQB:MRNA), a leading nucleic acid-based drug discovery and development company focused ...
San Diego, CA- May 10, 2016 – Objective Capital Partners, a leading middle market investment bank focused on transactions for companies with enterprise values up ...
Bothell, WA – February 18, 2016 – Marina Biotech, Inc. (OTCQB: MRNA), a leading nucleic acid-based drug discovery and development company focused on rare diseases, announced ...
AVACEN Explores Strategic Business Alternatives San Diego, CA – February 2, 2016 – AVACEN Medical, a privately held medical device company, announced that its Board ...
San Diego, CA – November 6th, 2014 – Objective Capital Partners, a leading middle market investment bank focused on transactions for privately held companies with ...
